Intradiscal Steroid Temporarily Alleviates Lower Back Pain
By HospiMedica International staff writers Posted on 06 Apr 2017 |
A single intradiscal injection of glucocorticoid (GC) is associated with reduced short-term low back pain (LBP) in patients with active discopathy, according to a new study.
Researchers at Université Paris Descartes, Hôpital Roger Salengro, and other institutions conducted a prospective, randomized, controlled study involving 135 patients with chronic LBP with active discopathy as demonstrated on magnetic resonance imaging (MRI), treated at three tertiary care centers in France. Study patients received a single GC intradiscal injection of 25 mg prednisolone acetate during discography (67 patients), while control patients underwent discography alone (68 patients).
The researchers found that percentage of patients with LBP intensity lower than 40 on an 11-point numerical rating scale was higher in the study group than the control group at one month after the intervention (55.4% versus 33.3%, respectively); there was no between-group difference in LBP intensity at 12 months. Secondary outcomes, such as spine-specific limitations in activities, health-related quality of life, anxiety and depression, employment status, and analgesic use did not differ between the groups at one or 12 months. The study was published on March 21, 2017, in Annals of Internal Medicine.
“Our results do not support the wide use of an injection of glucocorticoid in alleviating symptoms in the long term in this condition; the findings are consistent with earlier studies,” concluded lead Christelle Nguyen, MD, PhD, of Paris Descartes University, and colleagues. “Patients who did or didn't receive a steroid injection ended up in similar circumstances, with the same incidence of disc inflammation, lower quality of life, more anxiety and depression, and continued use of non-narcotic pain pills.”
Many spinal conditions, including a lumbar herniated disc, can cause inflammation or pressure on the nerve roots leading out of the spine, resulting in pain, tingling, or numbness. A lumbar epidural GC injection may be used to reduce the inflammation around the spinal nerves. But studies have shown that epidural steroid injections play a limited role in providing short-term pain relief, with an average time of two to six weeks after injection.
Researchers at Université Paris Descartes, Hôpital Roger Salengro, and other institutions conducted a prospective, randomized, controlled study involving 135 patients with chronic LBP with active discopathy as demonstrated on magnetic resonance imaging (MRI), treated at three tertiary care centers in France. Study patients received a single GC intradiscal injection of 25 mg prednisolone acetate during discography (67 patients), while control patients underwent discography alone (68 patients).
The researchers found that percentage of patients with LBP intensity lower than 40 on an 11-point numerical rating scale was higher in the study group than the control group at one month after the intervention (55.4% versus 33.3%, respectively); there was no between-group difference in LBP intensity at 12 months. Secondary outcomes, such as spine-specific limitations in activities, health-related quality of life, anxiety and depression, employment status, and analgesic use did not differ between the groups at one or 12 months. The study was published on March 21, 2017, in Annals of Internal Medicine.
“Our results do not support the wide use of an injection of glucocorticoid in alleviating symptoms in the long term in this condition; the findings are consistent with earlier studies,” concluded lead Christelle Nguyen, MD, PhD, of Paris Descartes University, and colleagues. “Patients who did or didn't receive a steroid injection ended up in similar circumstances, with the same incidence of disc inflammation, lower quality of life, more anxiety and depression, and continued use of non-narcotic pain pills.”
Many spinal conditions, including a lumbar herniated disc, can cause inflammation or pressure on the nerve roots leading out of the spine, resulting in pain, tingling, or numbness. A lumbar epidural GC injection may be used to reduce the inflammation around the spinal nerves. But studies have shown that epidural steroid injections play a limited role in providing short-term pain relief, with an average time of two to six weeks after injection.
Latest Critical Care News
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events